Myasthenia Gravis Support Group
Myasthenia gravis (MG) is a neuromuscular disease leading to fluctuating muscle weakness and fatiguability. The hallmark of myasthenia gravis is muscle weakness that increases during periods of activity and improves after periods of rest. Although myasthenia gravis may affect any voluntary muscle, muscles that control eye and eyelid movement, facial expression, and...
As we get older (over 30) we start to lose like two percent of testosterone every year afterwards.
The fact that you had hypogonadism as described sounds congenital. Especially If it had been happening for many years. Combine that then with the natural aging process and it kicks in to set it on overdrive.
I haven't seen anything to suggest a true correlation between low testosterone and MG.
However, I have read in a few places that DHEA does help with MG. It needs to be looked into if it hasn't already:
http://www.ncbi.nlm.nih.gov/pubmed/12757262
http://jaha.ahajournals.org/content/2/6/e000272.full (2013)
It appears to me that hypogonadism is much more fraught with health issues than testosterone replacement therapy
some statements from the article:
"A growing body of evidence suggests that men with lower levels of endogenous testosterone are more prone to develop Coronary Artery Disease during their lifetimes"
"There is growing evidence supporting an inverse relationship between the degree of testosterone deficiency and the severity of coronary artery disease." (low testosterone = more severe CAD)
"Existing evidence seems to suggest that lower levels of endogenous testosterone are associated with higher rates of allcause mortality and cardiovascular mortality."
"clinical data from 1031 male veterans in a retrospective observational study. The authors showed that treatment with testosterone in middleaged men with low levels of endogenous testosterone was associated with decreased mortality compared with that in hypogonadal men who did not receive testosterone supplementation."
There are many more correlations with low testosterone and diabetes, obesity, cholesterol, inflammation...
The article continues with adverse effects of testosterone replacement
"This included cases of prostate cancer, which showed no significant difference between the testosterone group and the placebo group."
"Existing evidence seems to suggest that the most commonly encountered adverse event associated with testosterone replacement therapy is an increase in hematocrit, which is considered a known physiologic function of testosterone" (increase in red blood cell numbers).
The article carefully looks at a few studies that showed more heart problems in the testosterone replacement groups. The evaluations list the limitations that question the results.
There is a large study TEAAM going on to find out more about the issue. But in the mean time, the AHA article is reassuring that testosterone replacement in men with hypogonadism is likely better for us than not doing it.